Healthcare Industry Molecular Diagnostics Market Analysis | Page 3

Your Catalyst To a Lucrative Business
Table of Content of Molecular Diagnostics Market
Chapter 1 Methodology & Scope
1.1 Research Methodology
1.1.1 Initial data exploration
1.1.2 Statistical modeling and forecast
1.1.3 Industry insights and validation
1.2 List of Data Sources
Chapter 2 Executive Summary
2.1 Molecular diagnostics industry 3600 perspective, 2016 - 2024
Chapter 3 Molecular Diagnostics Industry Insights
3.1 Market segmentation
3.2 Industry size, forecast and growth expectations, 2016 - 2024
3.3 Industry dynamics
3.3.1 Growth drivers
3.3.1.1 Technological advancements
3.3.1.2 Growing POC demand
3.3.1.3 Increasing geriatric population
3.3.1.4 Considerable R&D initiatives
3.3.1.5 Upward trend in disease prevalence
3.3.2 Industry pitfalls and challenges
3.3.2.1 Unclear regulatory landscape
3.3.2.2 Cost concerns
3.4 Key growth opportunities
3.4.1 Regional opportunities
3.4.2 Disease type opportunities
3.5 Porter’s analysis
3.6 PESTEL analysis
3.7 Company market share analysis, 2016
3.7.1 Key product landscape
3.7.2 Competitive landscape
Chapter 4 Molecular Diagnostics Infectious Disease Insights
4.1 Molecular diagnostics market share by infectious disease, 2016 & 2024
4.2 Flu
4.2.1 Market estimates and forecast, 2016 - 2024 (USD Million)
4.2.2 Market estimates and forecast by region, 2016 - 2024 (USD Million)
4.3 RSV (Respiratory Syncytial Virus)
4.3.1 Market estimates and forecast, 2016 - 2024 (USD Million)
4.3.2 Market estimates and forecast by region, 2016 - 2024 (USD Million)
4.4 Tuberculosis
4.4.1 Market estimates and forecast, 2016 - 2024 (USD Million)
4.4.2 Market estimates and forecast by region, 2016 - 2024 (USD Million)
Follow Us: